Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Amgen (NASDAQ:AMGN) Stock Rating Upgraded by Citigroup
Jim Cramer shakes up stock watchlist — 3 are out, rest stick around
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Decreased by Lifeworks Advisors LLC
Amgen Inc. (NASDAQ:AMGN) Shares Sold by ING Groep NV
Citi initiates coverage on 5 new biotech stocks By Investing.com
KBC Group NV Raises Position in Amgen Inc. (NASDAQ:AMGN)
Bell Bank Cuts Stake in Amgen Inc. (NASDAQ:AMGN)
Is Wall Street Bullish or Bearish on Amgen Stock?
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate - November 14, 2024 - Zacks.com
MOORE LAW ENCOURAGES AMGEN INC. INVESTORS TO CONTACT LAW FIRM | Morningstar
Trade Tracker: Joe Terranova sells Amgen and buys XBI
No link between experimental weight loss drug and change in bone density, Amgen says
Syros slammed by phase III data with tamibarotene in MDS | BioWorld
Arjuna Capital Lowers Stock Position in Amgen Inc. (NASDAQ:AMGN)
Morning Brew: Amgen's Rebound, Flutter's Buyback, and Cybersecurity Surge
Citi sets Amgen neutral with $335 target on MariTide focus By Investing.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Rakuten Securities Inc.
Buck Wealth Strategies LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN)
Aptus Capital Advisors LLC Buys 5,515 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Says No Link Between MariTide, Bone Density Loss | Morningstar
Amgen sees no bone safety concerns around experimental obesity drug, ETPharma
Amgen Says No Link Between MariTide And Changes In Bone Mineral Density
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA | Morningstar
Amgen Issues Statement on MariTide Phase 1 data By Investing.com
Amgen sees no bone safety concerns around experimental obesity drug By Reuters
Wall Street indexes dip with focus on Trump policies, economic data
Amgen stock holds steady as company dismisses analyst report | BioWorld
Amgen sinks as Cantor flags issues with obesity drug
Dollar rally continues while T-Notes are sold ahead of CPI - Newsquawk US Market Wrap
Amgen Inc. (NASDAQ:AMGN) Stock Position Cut by Victory Capital Management Inc.
USFDA gives nod to Alembic Pharma’s genetic formulation to treat heart failure
Proactive Wealth Strategies LLC Acquires New Holdings in Amgen Inc. (NASDAQ:AMGN)
BMO maintains Outperform on Amgen, price target at $362 By Investing.com
Barclays maintains Amgen at Equalweight with $315 target By Investing.com
Amgen (NASDAQ:AMGN) Earns "Outperform" Rating from William Blair
Winslow Asset Management Inc. Has $6.93 Million Holdings in Amgen Inc. (NASDAQ:AMGN)
Jefferies maintains buy on Amgen, keeps $380 target By Investing.com
WealthPlan Investment Management LLC Has $12.55 Million Holdings in Amgen Inc. (NASDAQ:AMGN)
WealthPLAN Partners LLC Acquires 1,594 Shares of Amgen Inc. (NASDAQ:AMGN)
Cantor maintains $405 target on Amgen amid new data By Investing.com
WCM Investment Management LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN)
TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV) | Markets Insider
Alembic Pharmaceuticals receives USFDA approval for Ivabradine Tablets | Capital Market News - Business Standard
deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk - PR Newswire APAC
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Nations Financial Group Inc. IA ADV
Core Wealth Partners LLC Purchases 449 Shares of Amgen Inc. (NASDAQ:AMGN)
Baker Avenue Asset Management LP Buys 1,662 Shares of Amgen Inc. (NASDAQ:AMGN)
Colonial River Investments LLC Trims Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Axxcess Wealth Management LLC Sells 2,426 Shares of Amgen Inc. (NASDAQ:AMGN)
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Arrow Financial Corp
First Personal Financial Services Reduces Holdings in Amgen Inc. (NASDAQ:AMGN)
CWA Asset Management Group LLC Purchases New Position in Amgen Inc. (NASDAQ:AMGN)
Objective Capital Management LLC Invests $443,000 in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Assetmark Inc.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2024 Earnings Call Transcript
Executive Wealth Management LLC Buys Shares of 24,456 Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Leavell Investment Management Inc.
Portside Wealth Group LLC Sells 60 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Position Trimmed by Easterly Investment Partners LLC
Amgen Inc. (NASDAQ:AMGN) Shares Bought by ARK Investment Management LLC
Consolidated Planning Corp Purchases 1,842 Shares of Amgen Inc. (NASDAQ:AMGN)
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS | INN
Ascent Wealth Partners LLC Has $2.89 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)
Wilkinson Global Asset Management LLC Has $91.89 Million Stake in Amgen Inc. (NASDAQ:AMGN)
JB Capital LLC Raises Holdings in Amgen Inc. (NASDAQ:AMGN)
Castle Wealth Management LLC Acquires 2,207 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Position Reduced by Wilkinson Global Asset Management LLC
BNC Wealth Management LLC Invests $4.10 Million in Amgen Inc. (NASDAQ:AMGN)
M&G Plc Has $91.13 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Radnor Capital Management LLC Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Avidian Wealth Enterprises LLC
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Catalyst Capital Advisors LLC
Global Pharma and Biotech Summit: The Impact of Politics on Pharma and Biotech
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - November 6, 2024 - Zacks.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Legacy CG LLC
Healthcare MNCs: Import expo vital growth driver
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - November 5, 2024 - Zacks.com
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now?
Van ECK Associates Corp Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
UBS Group Issues Pessimistic Forecast for Amgen (NASDAQ:AMGN) Stock Price
What is Leerink Partnrs’ Estimate for Amgen FY2026 Earnings?
Amgen (NASDAQ:AMGN) Upgraded at StockNews.com
Amgen (NASDAQ:AMGN) Rating Increased to Strong-Buy at StockNews.com
Biechele Royce Advisors Sells 2,224 Shares of Amgen Inc. (NASDAQ:AMGN)
Lowe Brockenbrough & Co. Inc. Reduces Holdings in Amgen Inc. (NASDAQ:AMGN)
Sitrin Capital Management LLC Sells 88 Shares of Amgen Inc. (NASDAQ:AMGN)
UBS Group Cuts Amgen (NASDAQ:AMGN) Price Target to $326.00
Stephens Inc. AR Sells 1,750 Shares of Amgen Inc. (NASDAQ:AMGN)
Americana Partners LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN)
Stephens Inc. AR Has $16.99 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)
What is William Blair's Estimate for Amgen FY2024 Earnings?
Hudson Valley Investment Advisors Inc. ADV Has $403,000 Position in Amgen Inc. (NASDAQ:AMGN)
Earnings call: Regeneron reports robust Q3 growth, Dupixent shines By Investing.com
Dow Jones Industrial Average sinks over 200 points on risk aversion
O ROURKE & COMPANY Inc Has $395,000 Holdings in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Oak Harvest Investment Services
Earnings call: Amgen reports robust Q3 growth with $8.5 billion in revenue By Investing.com